Profile Details

Create Project

★★★★★

☆☆☆☆☆

USD 28 /hr

★★★★★

☆☆☆☆☆

Hire Dr. Annisa Salsabilla D.

Indonesia

USD 28 /hr

Academic Researcher and Medical Doctor | R, SPSS, STATA, Tableau | 45+ awards, 5+ first author on Q1 publications

Profile Summary

Annisa Salsabilla Dwi Nugrahani is a medical researcher and future Master’s student at Harvard Medical School (2025-2027), specializing in biomarkers, endocrinology, and clinical investigation. With a strong background in meta-analyses, systematic reviews, and translational research, she has contributed to over 10 publications and presented at international medical conferences. She has won 30+ research competitions, including the Outstanding Abstract Award (JSMO 2024), and secured full funding from the Indonesian Government (LPDP) for her graduate studies. Passionate about bridging research and clinical practice, Annisa aims to advance precision medicine and metabolic disease research, while actively seeking global collaborations in medical science.

Subject Matter Expertise

• ☆ Molecular Biology
• ☆ Biomarkers
• ☆ SPSS
• ☆ STATA
• ☆ R
• ☆ Tableau
• ☆ Primary Care/Family Medicine
• ☆ Preventive Medicine
• ☆ Precision Medicine
• ☆ Internal Medicine

Services

• Writing

Writing Medical Writing, General Proofreading & Editing

Work Experience

Researcher

Advanced Research Center

July 2023 - Present

Graduate Research Assistant / Research Assistant

The University of Western Australia

July 2022 - January 2025

Research Assistant - Research Associate

Mahidol University

July 2022 - August 2022

Education

Doctor of Medicine

Airlangga University

August 2019 - January 2025

Certifications

• Certification details not provided.

Publications

JOURNAL ARTICLE

Annisa Salsabilla Dwi Nugrahani, Farizal Rizky Muharram, Hermina Novida, Julian Benedict Swannjo, Sony Wibisono, Citrawati Dyah Kencono Wungu (2025). Trends and disability-attributable risk factors of type 2 diabetes mellitus in Southeast Asia (1990–2019): An in-depth 30-year analysis from the Global Burden of Disease study . Nutrition, Metabolism and Cardiovascular Diseases.

Annisa Salsabilla Dwi Nugrahani, Herni Basir, Andi Makbul Aman, Syakib Bakri, Haerani Rasyid, Husaini Umar, Faridin H. P., Andi Muhammad Ichsan, Andi Alfian Zainuddin (2024). The association between fibroblast growth factor 21 with diabetes retinopathy among type 2 diabetes mellitus patients: a systematic review, meta-analysis, and meta-regression . PeerJ.

M.R. Putra, A.D. Nugrahani (2024). MO61-1 Efficacy of DA-EPOCH-R as first-line therapy for diffuse large B-cell lymphoma: a comprehensive review and meta-analysis . Annals of Oncology.

Annisa Salsabilla Dwi Nugrahani, Gwenny Ichsan Prabowo, Agung Pranoto, Citrawati Dyah Kencono Wungu, Bayu Satria Wiratama (2024). Association of manganese superoxide dismutase Ala16Val gene polymorphism with diabetic retinopathy risk in type 2 diabetes: A systematic review and meta-analysis . Electronic Journal of General Medicine.

Nugrahani, A.S.D., Prabowo, G.I., Pranoto, A., Wungu, C.D.K., Wiratama, B.S.(2024). Association of manganese superoxide dismutase Ala16Val gene polymorphism with diabetic retinopathy risk in type 2 diabetes: A systematic review and meta-analysis . Electronic Journal of General Medicine. 21. (3).

Annisa Salsabilla Dwi Nugrahani, Lintang Cahyaning Ratri, Gwenny Ichsan Prabowo, Jongky Hendro Prajitno(2022). Methylene Blue: a Potential Novel Treatment in Diabetic Foot Ulcer . Jurnal Profesi Medika : Jurnal Kedokteran dan Kesehatan. 16. (2). Fakultas Kedokteran {UPN} Veteran Jakarta

Annisa Salsabilla Dwi Nugrahani, Yuri Widia(2022). The Utilization of Nanoemulsified Aminolevulinic Acid in Photodynamic Therapy for Actinic Keratosis . International Journal of Research Publications. 114. (1). International Journal of Research Publications